144 related articles for article (PubMed ID: 17700567)
1. Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Br J Cancer; 2007 Sep; 97(6):755-60. PubMed ID: 17700567
[TBL] [Abstract][Full Text] [Related]
2. Melatonin modulates aromatase activity and expression in endothelial cells.
Alvarez-García V; González A; Martínez-Campa C; Alonso-González C; Cos S
Oncol Rep; 2013 May; 29(5):2058-64. PubMed ID: 23450505
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Alvarez-García V; Sánchez-Barceló EJ; Cos S
Oncol Rep; 2010 Apr; 23(4):1173-8. PubMed ID: 20204307
[TBL] [Abstract][Full Text] [Related]
4. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
5. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
7. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
Lou YR; Murtola T; Tuohimaa P
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):151-7. PubMed ID: 15862960
[TBL] [Abstract][Full Text] [Related]
9. Aromatase, the enzyme responsible for estrogen biosynthesis, is expressed by human and rat glioblastomas.
Yague JG; Lavaque E; Carretero J; Azcoitia I; Garcia-Segura LM
Neurosci Lett; 2004 Sep; 368(3):279-84. PubMed ID: 15364411
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor induces elevation of steroid 5alpha-reductase mRNA levels in rat C6 glioma cells through expression of transcription factor Egr-1.
Her S; Arimochi H; Morita K
Brain Res Mol Brain Res; 2004 Jul; 126(2):157-64. PubMed ID: 15249139
[TBL] [Abstract][Full Text] [Related]
11. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
14. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Mateos S; Hill SM; Sánchez-Barceló EJ; Cos S
Oncol Rep; 2007 Apr; 17(4):947-53. PubMed ID: 17342341
[TBL] [Abstract][Full Text] [Related]
15. Aromatase is abundantly expressed by neonatal rat penis but downregulated in adulthood.
Jesmin S; Mowa CN; Sakuma I; Matsuda N; Togashi H; Yoshioka M; Hattori Y; Kitabatake A
J Mol Endocrinol; 2004 Oct; 33(2):343-59. PubMed ID: 15525594
[TBL] [Abstract][Full Text] [Related]
16. Aromatase and the breast: regulation and clinical aspects.
Miller WR
Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
[TBL] [Abstract][Full Text] [Related]
17. Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.
Martínez-Campa C; González A; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Breast Cancer Res Treat; 2005 Dec; 94(3):249-54. PubMed ID: 16244789
[TBL] [Abstract][Full Text] [Related]
18. Regulation of aromatase gene expression in purified germ cells of adult male rats: effects of transforming growth factor beta, tumor necrosis factor alpha, and cyclic adenosine 3',5'-monosphosphate.
Bourguiba S; Chater S; Delalande C; Benahmed M; Carreau S
Biol Reprod; 2003 Aug; 69(2):592-601. PubMed ID: 12700195
[TBL] [Abstract][Full Text] [Related]
19. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
20. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]